Share profile
Up and Coming
Provided by Xin Tao
A former research scientist, Xin brings a deep understanding of the complex scientific issues that relate to the US legal compliance and government enforcement issues, enabling him to help clients with all phases of product development, manufacturing, and marketing. As the science and technology continues to evolve, Xin supports our clients to constantly innovate and push the boundaries of what's possible in the world of science.
Xin's practice focuses on advising high-growth companies and investors in food and beverage, healthcare, and e-commerce industries globally. As part of the Firm's US Government Enforcement Practice, he has represented many global companies during high-stakes US government investigations (including actions initiated by the US Congress, US Department of Justice (DOJ), and US Food and Drug Administration (FDA)) around the world. Xin also has a strong track record in US consumer product recall matters, and with a deep understanding of the intricacies involved in navigating the complex and interrelated legal and scientific issues, Xin can creatively and effectively represent companies in these bet-the-company cases.
As a seasoned US government regulatory and enforcement counsel, Xin works closely with global companies with novel pharmaceutical, medical device, food, and cosmetic applications that require the US government's pre-market approval or clearance and FDA Current Good Manufacturing Practices (cGMP) compliance.
• Co-author. "Key Legal Trends for Healthcare And Life Sciences In 2024," Law360, 8 January 2024
• Co-author. "Staying ahead of FDA drug cGMP enforcement," JD Supra, 03 February 2023
• Co-author. "Assuring the Food Safety of Crops Developed through Breeding," ACS Agricultural Science & Technology, 2022
• Co-author, "FDA completes first pre-market consultation for human food made with animal cell culture technology," JD Supra, 21 November 2022
• Co-author, "FDA Cites Five Companies for Illegally Selling Delta-8 THC and CBD Products," JD Supra, 18 May 2022
• Co-author, "What To Do As PFAS Food Packaging Phaseouts Approach," Law360, 21 January 2022
USA
English
Mandarin
Georgetown University Law Center
JD
2012
Texas A&M University
MS
2009
Shanghai Jiao Tong University
BS
2006
Provided by Chambers
Tao Xin of is head of Baker McKenzie's US food and drug law practice. He has significant expertise across the full spectrum of FDA regulations.
Provided by Chambers
"His dedication to his clients stands out; he goes above and beyond to do whatever we need. He's really pragmatic with his advice too."
"He's very responsive and client-friendly."
"His dedication to his clients stands out; he goes above and beyond to do whatever we need. He's really pragmatic with his advice too."
"He's very responsive and client-friendly."
